Cambridge Investment Research Advisors
HEPA

Cambridge Investment Research Advisors’s Hepion Pharmaceuticals HEPA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– -$8K – 2125
2017
Q3 		– Hold
0
– – – 1995
2017
Q2 		– Hold
0
– – – 1925
2017
Q1 		– Hold
0
– – – 1745
2016
Q4 		– Hold
0
– – – 1650
2016
Q3 		– Hold
0
– – – 1725
2016
Q2 		– Hold
0
– – – 1536
2016
Q1 		– Hold
0
– – – 1579
2015
Q4 		– Hold
0
– – – 1538
2015
Q3 		– Hold
0
– – – 1381

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return